StockNews.com Begins Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)
StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Shares of NASDAQ:TTNP opened at $0.42 on Tuesday. The firm has a fifty day moving average price of […]
More Stories
Are You Responsible for Your Deceased Spouse’s Debts
By Anne Johnson It’s hard enough when a spouse dies, but having to worry about their debts can be overwhelming....
Indy 500: Larson’s Double Attempt, Newgarden’s Three-Peat Quest Among Top Storylines
By Ross Kelly The Greatest Spectacle in Racing turns 109 this year as the 2025 Indianapolis 500 takes place Sunday...
Crude Oil Prices Decline Amid Unexpected US Inventory Buildup
By Naveen Athrappully An unexpected increase in U.S. crude oil stocks contributed to a drop in oil prices in early...
What to Know About Trump’s Battle With Watchdog Agency Over Federal Spending
By Joseph Lord The stage is set for a constitutional battle between President Donald Trump and a federal watchdog over...
More Than 1,000 Troops Sent to Secure Southern Border in Latest Deployment
By John Rigolizzo The Trump administration is deploying more than 1,000 additional troops to help secure the southern border, U.S....
Here Are the Countries That Have Reached, or Are Considering, Deportation Deals With US
By Savannah Hulsey Pointer President Donald Trump’s illegal immigrant deportation push has officials looking for new places to put illegal...